BLTE

Conviction 70HealthcareScan · Thu, Sep 24, 2026

Belite Bio, Inc (BLTE) closed at $169.60 (+0.55%) on Sep 24, 2026. Price is above its 50-day and above its 200-day moving average. RSI(14) 51, RS Rating 97, -12.4% from its 52-week high, +6.5% year to date. Sector: Healthcare · Biotechnology.

BLTE$169.60+0.55%

ResistanceSupportVol 14Insider sell

Vol MA14 246.83K

Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24

BELITE BIO, INCBiotechnologywww.belitebio.com ↗

Price169.60

Change+0.55%

Gap-0.54%

Rel volume—

Avg volume220.49K

Avg $ vol38.84M

SMA 20170.57

SMA 50164.40

SMA 200160.40

Price vs 50+3.16%

Price vs 200+5.74%

MA stackbullish

50/200 cross—

Supertrendup · 166.62

RSI (14)51

MACD hist-0.88

MACD crossbear · 6d

Stoch %K / %D12 / 26

ADX (14)16

+DI / −DI26 / 25

RSI divergence—

MACD divergence—

ATR %4.17%

ADR %4.28%

52w high193.61

52w low69.80

From 52w high-12.40%

Above 52w low+142.98%

New 52w highNo

SqueezeOff

Bollinger width25.21%

%B0.48

Donchian pos40.15%

Donchian high198.58

Donchian low150.16

AVWAP (52w high)161.58

vs AVWAP high+4.97%

AVWAP (52w low)154.53

vs AVWAP low+9.75%

OBV trendFlat

Chaikin MF (20)0.10

Today vs 20d—

Avg vol (14d)246.83K

Avg vol (20d)220.49K

Avg $ vol (20d)38.84M

Market cap6.67B

RS Rating97 / 99

RS 3m (vs SPY)+8.70%

RS 6m (vs SPY)-7.43%

RS line new highNo

Trend template6/8

Technical rank74.6

1 week-0.44%

1 month+4.90%

3 months+13.19%

6 months+9.39%

1 year+138.71%

YTD+6.49%

P/E—

P/B8.66

P/S—

P/FCF—

EPS—

Div yield—

ROE—

ROA—

Debt/Eq—

Current50.02

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth—

Price target236.86

Target upside39.66%

Analyst ratingBuy

Institutional23.54%

Ent. value6.32B

Revenue—

Net income—

Gross profit—

Free cash flow—

IndustryBiotechnology

ExchangeNasdaq

Shares out40.09M

Employees41

ListedFri, Apr 29, 2022

Free float19.55M

Float %48.5%

Short interest1.05M

Days to cover7.4d

Short volume39.5%

Squeeze score36 / 100

Next earnings—

EPS forecast—

Last EPS vs est−$0.70 vs −$0.73

Last surprise+4.1% beat

Setup gradeB

Conviction70 / 100

Pattern quality—

Tech rank74.6 / 100

Group rank59 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance190.07

Support151.52

Days since event—

Candle confirm—

Congress activity

Disclosed STOCK Act trades in BLTE

All disclosures →

No recent disclosed trades by Congress in BLTE. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in BLTE · open-market 10 sells

Insider	Side	Shares	Value	Traded	Filed
Chuang Hao-Yuan Chief Financial Officer · American depositary share · 2026-09-08	Sell	2.56K	$507K	2026-09-08	2026-09-09
Chuang Hao-Yuan Chief Financial Officer · American depositary share · 2026-09-08	Sell	2.2K	$427K	2026-09-08	2026-09-09
Chuang Hao-Yuan Chief Financial Officer · American depositary share · 2026-09-08	Sell	4.12K	$806K	2026-09-08	2026-09-09
Chuang Hao-Yuan Chief Financial Officer · American depositary share · 2026-09-08	Sell	4.47K	$879K	2026-09-08	2026-09-09
Chuang Hao-Yuan Chief Financial Officer · American depositary share · 2026-09-08	Sell	4.61K	$908K	2026-09-08	2026-09-09
Lin Yu-Hsin Chief Executive Officer · American depositary share · 2026-09-08	Sell	2.4K	$466K	2026-09-08	2026-09-09
Lin Yu-Hsin Chief Executive Officer · American depositary share · 2026-09-08	Sell	6.09K	$1.2M	2026-09-08	2026-09-09
Lin Yu-Hsin Chief Executive Officer · American depositary share · 2026-09-08	Sell	6.06K	$1.2M	2026-09-08	2026-09-09
Lin Yu-Hsin Chief Executive Officer · American depositary share · 2026-09-08	Sell	8.75K	$1.7M	2026-09-08	2026-09-09
Lin Yu-Hsin Chief Executive Officer · American depositary share · 2026-09-08	Sell	2.7K	$535K	2026-09-08	2026-09-09

SEC filings

EDGAR filings in BLTE · 8 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.